Top 20 Xiidra alternatives

4 min read

Get started

Trusted by data-driven investors

In 2025, the US offers diverse alternatives to Xiidra for dry eye disease management, including Signal12's Pro-ocularâ„¢, harnessing advanced delivery systems in Greenwich, and Olympic Ophthalmics' iTEAR100 neuromodulation device from Issaquah. Firms like Inoculus Ventures in Raleigh advance laboratory diagnostics, while Summit Eye Center in Lee's Summit delivers tailored surgeries. Across California, entities like East Bay Eye Center and Beach Eye Medical Group excel in vision health. These companies uniquely address dry eye with proprietary solutions, cutting-edge diagnostics, and patient-focused care.

Signal12 logo

Signal12

🇺🇸 Greenwich, CT, US

Signal12 is a clinical-stage biopharmaceutical firm specializing in innovative drug therapies for Dry Eye Disease, notably through its proprietary topical treatment, Pro-ocularâ„¢, which employs a unique transappendageal delivery system and targets the ophthalmic branch of the trigeminal nerve.

pharmaceutical
manufacturing
clinical-stage
biopharmaceutical
drug therapies
dry eye
ophthalmic
transappendageal delivery
trigeminal nerve
clinical studies
drug delivery
Company size: 11-50
Olympic Ophthalmics logo

Olympic Ophthalmics

🇺🇸 1065 12th Ave NW Issaquah, Washington 98027, US

Olympic Ophthalmics specializes in medical equipment manufacturing, focusing on innovative drug-free home-health solutions for ocular diseases. Their flagship product, the iTEAR100, utilizes neuromodulation technology to enhance natural tear production, addressing significant unmet needs in eye care.

medical devices
ophthalmology
neuromodulation
ocular diseases
home health
tear production
FDA clearance
therapeutic devices
energy-based technology
parasympathetic pathway
Company size: 2-10
Founded: 2017
reVision Therapeutics, Inc. logo

reVision Therapeutics, Inc.

🇺🇸 Ridgewood, NJ 07450, US

ReVision Therapeutics focuses on developing innovative ophthalmic medicines by repurposing approved drugs and rescuing shelved therapies to address unmet needs in eye disorders. Their unique approach allows for faster and more cost-effective development of impactful treatments, including options for Stargardt disease and dry eye disease.

ophthalmic medicines
drug repurposing
retinal disease
Stargardt disease
dry eye
vitreoretinopathy
intravitreal delivery
therapeutic development
unmet needs
commercial potential
innovative therapies
Company size: 2-10
Founded: 2018
Inoculus Ventures logo

Inoculus Ventures

🇺🇸 Raleigh, NC 27612, US

Inoculus Ventures specializes in developing innovative treatments for dry eye disease within the medical and diagnostic laboratories industry. Their focus on novel therapeutic solutions positions them as a key player in addressing this prevalent condition.

medical laboratories
diagnostics
treatments
dry eye
ophthalmology
healthcare innovation
Company size: 2-10
Cure Stat Rx logo

Cure Stat Rx

🇺🇸 6725 Mesa Ridge Road Suite 230

Cure Stat Rx specializes in pharmaceutical manufacturing, focusing on home infusion and specialty pharmacy services that provide high-quality compounded and specialty medications. With a commitment to pioneering treatments for rare and chronic diseases, it offers personalized service and competitive pricing, along with expertise in various therapeutic areas including oncology, immunotherapy, and pediatric compounding.

pharmaceutical manufacturing
infusion therapies
specialty pharmacy
compounded medications
oncology therapies
immunotherapies
sterile compounding
non-sterile compounding
fertility treatments
pediatric compounding
ophthalmic compounding
veterinary compounding
Company size: 11-50
Founded: 2017
Summit Eye Center logo

Summit Eye Center

🇺🇸 1621 NW Blue Pkwy Lees Summit, Missouri 64086, US

Summit Eye Center is a comprehensive ophthalmology practice specializing in cataract surgery, glaucoma treatment, and dry eye disease management, employing innovative, minimally invasive techniques and a tailored approach to patient care. The focus on advanced lens implant options and a wide range of treatments in a welcoming environment sets it apart in the medical practices industry.

ophthalmology
cataract
glaucoma
dry eye
eye care
surgical options
lens implants
minimally invasive
treatments
patient management
vision health
Company size: 11-50
Founded: 2005
Oculos Clinical logo

Oculos Clinical

🇺🇸 201 E Kennedy Blvd Suite 1775

Oculos Clinical is a full-service ophthalmic research organization specializing in pharmaceutical manufacturing, offering integrated solutions for pre-clinical testing, clinical research, and product development across various ophthalmological conditions. With a focus on delivering a complete product pathway from research to release, it leverages extensive expertise in clinical research, medical devices, and analytical chemistry.

ophthalmics
clinical research
pharmaceutical manufacturing
preclinical testing
toxicology
microbiology
analytical chemistry
medical devices
therapeutics
combination products
anti-infective
anti-inflammatory
Company size: 11-50
Founded: 2008
AxeroVision, Inc. logo

AxeroVision, Inc.

🇺🇸 5857 Owens Ave Carlsbad, California 92008, US

AxeroVision specializes in biotechnology research focused on developing innovative therapies for ophthalmic inflammatory diseases, particularly Dry Eye Disease and Meibomian Gland Dysfunction. Their lead candidates, AXR-159 and AXR-270, have demonstrated clinical proof-of-concept, highlighting their commitment to breakthrough treatments in the field of ophthalmology.

biotechnology
ophthalmology
therapies
inflammation
chronic disease
clinical research
proof-of-concept
Meibomian Gland Dysfunction
dry eye
treatment
Company size: 2-10
Founded: 2016

BioTheraVision

🇺🇸 Chicago, Illinois 60611, US

BioTheraVision specializes in advanced biotherapeutics, focusing on innovative solutions for disease treatment and prevention through cutting-edge research and development in the biotechnology industry. Their unique approach combines state-of-the-art technology with a commitment to improving patient outcomes.

""
Company size: 1
Harrow logo

Harrow

🇺🇸 1A Burton Hills Blvd Suite 200

Harrow is a leader in the ophthalmic pharmaceutical manufacturing industry, focusing on innovation and the provision of affordable, accessible medications. Its commitment to understanding the needs of healthcare providers and patients positions it as one of the fastest-growing entities in the ophthalmic healthcare market.

ophthalmic
healthcare
pharmaceuticals
manufacturing
innovation
medications
accessibility
quality
providers
patients
financial growth
Company size: 201-500
Founded: 2012
Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

🇺🇸 15 Crosby Drive Bedford, MA 01730, US

A biopharmaceutical firm specializing in the development and commercialization of innovative ophthalmic therapies, utilizing proprietary bioresorbable hydrogel technology to enhance drug delivery solutions. Their product pipeline includes FDA-approved treatments for ocular inflammation, pain, and elevated intraocular pressure, positioning them as a leader in the ophthalmic sector.

ophthalmic therapies
drug delivery
bioresorbable hydrogel
ocular inflammation
sustained delivery
glaucoma
wet AMD
diabetic retinopathy
corticosteroid
ocular hypertension
dry eye disease
specialty sales
Company size: 51-200
Founded: 2006
Bruder Healthcare logo

Bruder Healthcare

🇺🇸 1115 Ridgeland Pkwy 101

Bruder Healthcare specializes in the manufacturing of innovative medical equipment focused on ocular health and wellness, offering a range of therapeutic products for dry eye management and natural pain relief. Their patented technologies emphasize safety, efficacy, and convenience, making them a leader in the therapeutic eyecare industry.

medical equipment
therapeutic products
dry eye
pain relief
ocular health
analgesic products
eye compress
cold therapy
hygiene products
ophthalmic instruments
Company size: 11-50
Founded: 1986
Visus Therapeutics, Inc. logo

Visus Therapeutics, Inc.

🇺🇸 2 Nickerson St Suite 101

Visus Therapeutics is a clinical-stage biotechnology firm dedicated to developing innovative ophthalmic therapies aimed at enhancing vision, particularly targeting presbyopia through novel once-daily eye drops. The focus on advanced drug delivery technology and a diverse pipeline addressing various eye conditions positions it uniquely in the ophthalmology sector.

biotechnology
ophthalmic therapies
presbyopia
eye health
glaucoma
macular degeneration
ocular surface disease
drug delivery
clinical-stage
pharmaceutical
innovative formulations
controlled-release
Company size: 11-50
Founded: 2019
Cloudbreak Pharma logo

Cloudbreak Pharma

🇺🇸 8921 Research Dr Irvine, California 92618, US

An innovation-driven clinical-stage biotechnology firm focused on developing ophthalmic drugs for chronic eye diseases, featuring a diverse pipeline of seven drug candidates. Notably, its lead candidate, CBT-001, aims to address pterygium, an underdiagnosed condition with no existing approved treatments, through targeted mechanisms and specialized formulations for ocular delivery.

biotechnology
ophthalmology
drug development
clinical trials
chronic eye diseases
targeted mechanisms
ocular delivery
investigational treatments
pterygium
drug candidates
Company size: 11-50
Founded: 2015
OcuSci Inc. logo

OcuSci Inc.

🇺🇸 Del Mar, CA 92014, US

Specializing in medical equipment manufacturing, OcuSci Inc. develops innovative products for the treatment of Dry Eye Disease, including the clinically proven MGrx Dry Eye Treatment System for in-clinic use and a best-in-class Dry Eye Compress that offers therapeutic moist-heat therapy. Their solutions provide rapid symptom relief and significant improvement within a month, addressing various related conditions effectively.

medical equipment
dry eye
ophthalmology
optometry
in-clinic treatment
home care
symptom relief
therapeutic compress
moist-heat therapy
macular degeneration
meibomian gland dysfunction
clinical products
Company size: 2-10
Founded: 2012
Eye Eco, Inc. logo

Eye Eco, Inc.

🇺🇸 40880 County Center Dr. Suite E & F Suite E & F

Eye Eco, Inc. is a medical device firm focused on developing innovative products and therapies that provide natural, long-lasting relief for dry, irritated eyes while promoting overall eye health. The organization emphasizes comfort and effectiveness in its offerings and actively contributes to charitable efforts aimed at curing chronic dry eye conditions.

medical device
dry eye
eye health
therapies
irritation relief
innovative products
chronic conditions
Sjogren's syndrome
Company size: 11-50
Founded: 2003
Oculus Research Inc logo

Oculus Research Inc

🇺🇸 958 Vandora Springs Rd Garner, North Carolina 27529, US

Oculus Research specializes in ophthalmic clinical research, focusing on a wide range of eye conditions and innovative treatment devices. With a patient-centered approach and extensive clinical research experience, it aims to advance pharmaceutical development in the field of optometry.

clinical research
ophthalmic
pharmaceuticals
glaucoma
conjunctivitis
blepharitis
dry eye
myopia
presbyopia
contact lenses
drug development
CRO
Company size: 2-10
Founded: 2012
Belite Bio logo

Belite Bio

🇺🇸 5820 Oberlin Drive, Suite 101 San Diego, California 92121, US

Belite Bio is a clinical-stage biotechnology firm focused on developing innovative treatments for untreatable eye diseases and metabolic disorders, with a lead oral therapy, Tinlarebant, currently in phase 3 trials and recognized with multiple designations for its potential in addressing Dry AMD and Stargardt disease.

biotechnology
drug development
clinical research
eye diseases
retinal dystrophy
metabolic diseases
oral medication
Fast Track designation
phase 3 trials
dry AMD
Stargardt disease
Company size: 11-50
Founded: 2018
ForSight VISION5 (now Allergan) logo

ForSight VISION5 (now Allergan)

🇺🇸 191 Jefferson Dr Menlo Park, CA 94025, US

ForSight VISION5 specializes in pharmaceutical manufacturing, focusing on innovative, non-invasive products that replace traditional eye drops for sustained therapy in treating major anterior segment eye diseases, such as glaucoma and dry eye. Its lead product, the Helios(TM) insert, offers a novel delivery system that ensures continuous medication administration for patients.

pharmaceutical
manufacturing
non-invasive
ocular
glaucoma
dry eye
allergy
sustained therapy
drug delivery
insert
Company size: 11-50
Founded: 2010
MIEBO® (perfluorohexyloctane ophthalmic solution) logo

MIEBO® (perfluorohexyloctane ophthalmic solution)

MIEBO® is an ophthalmic solution in the pharmaceutical manufacturing industry, specializing in innovative treatments for eye care. Its unique formulation is designed to enhance ocular surface health, catering specifically to healthcare professionals in the U.S. market.

ophthalmic solution
pharmaceutical manufacturing
healthcare
prescription drugs
eye care
perfluorohexyloctane
drug safety
Company size: 1

Updated on

Let our AI browse all websites for you

Save time, improve accuracy, and get ahead of the competition with Cenco.ai.

Get started

You might be interested in